Research Centre for Toxic Compounds in the Environment (RECETOX), Faculty of Science, Masaryk University, Brno, Czech Republic.
Institute of Biostatistics and Analyses, Faculty of Medicine and Faculty of Science, Masaryk University, Brno, Czech Republic.
J Epidemiol Community Health. 2018 Apr;72(4):349-355. doi: 10.1136/jech-2017-209960. Epub 2018 Jan 25.
Prenatal and postnatal paracetamol exposure has been previously associated with asthma development in childhood in Western populations. We explore the association between prenatal and postnatal paracetamol exposure and asthma development in a Central European sample of Czech children, suggesting possible additive effect of the both exposures. Furthermore, since aspirin had been used more widely during study data collection in Central Europe, we also compared asthma development for those exposed to paracetamol and aspirin.
We used data from 3329 children born in the 1990s as members of the prospective Czech European Longitudinal Study of Pregnancy and Childhood. Data about prenatal and postnatal paracetamol and aspirin exposure, and potential covariates were obtained from questionnaires completed by mothers. Data about incident asthma were obtained from paediatrician health records.
60.9% of children received paracetamol only postnatally, 1.5% only prenatally and 4.9% of children were exposed both during pregnancy and infancy. Prevalence of asthma in following population was 5% at 11 years. Being exposed to paracetamol both in prenatal and postnatal period was associated with asthma development (unadjusted OR 1.98, 95% CI 1.02 to 3.87). Being exposed only in the postnatal period was also significantly associated with increased risk of asthma. No association between prenatal exposure only and outcome was found. A higher but non-significant risk of asthma was observed for those whose mothers used paracetamol during pregnancy compared with those who used aspirin.
The main findings of this prospective birth cohort study add to previous observations linking prenatal and early postnatal paracetamol exposure to asthma development. However, the magnitude of effect is relatively modest, and therefore, we recommend paracetamol to remain the analgesic and antipyretic of choice throughout pregnancy and early childhood.
先前的研究表明,产前和产后使用对乙酰氨基酚与西方人群儿童期哮喘的发展有关。我们在捷克儿童的中欧样本中探索了产前和产后使用对乙酰氨基酚与哮喘发展之间的关系,提示这两种暴露可能存在累加效应。此外,由于在中欧研究数据收集期间阿司匹林的使用更为广泛,我们还比较了暴露于对乙酰氨基酚和阿司匹林的儿童哮喘发展情况。
我们使用了 1990 年代出生的 3329 名儿童作为前瞻性捷克欧洲妊娠和儿童纵向研究的成员的数据。通过母亲填写的问卷获得有关产前和产后使用对乙酰氨基酚和阿司匹林的暴露情况以及潜在混杂因素的数据,并从儿科医生的健康记录中获得关于新诊断哮喘的数据。
60.9%的儿童仅在产后接受过对乙酰氨基酚治疗,1.5%仅在产前接受过治疗,4.9%的儿童在妊娠和婴儿期同时接受过治疗。在接下来的人群中,11 岁时哮喘的患病率为 5%。在产前和产后均暴露于对乙酰氨基酚与哮喘发展相关(未经调整的 OR 1.98,95%CI 1.02 至 3.87)。仅在产后暴露也与哮喘风险增加显著相关。仅在产前暴露与结果之间未发现关联。与使用阿司匹林的母亲相比,使用对乙酰氨基酚的母亲的儿童哮喘风险更高,但无统计学意义。
这项前瞻性出生队列研究的主要发现增加了先前关于产前和早期产后使用对乙酰氨基酚与哮喘发展之间关联的观察结果。然而,效应的幅度相对较小,因此,我们建议在整个孕期和儿童早期仍将对乙酰氨基酚作为镇痛和解热的首选药物。